🇺🇸 FDA
Patent

US 6350741

Inhibitors of interleukin-1&bgr; converting enzyme

expired A61KA61K38/00A61P

Quick answer

US patent 6350741 (Inhibitors of interleukin-1&bgr; converting enzyme) held by Vertex Pharmaceuticals Incorporated expires Mon Feb 21 2022 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Feb 26 2002 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 21 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K38/00, A61P, A61P19/08, A61P25/28